Modulation of TRPV expression levels

Details for Australian Patent Application No. 2006305657 (hide)

Owner Sylentis S.A.U.

Inventors Jimenez Anton, Ana Isabel; Acosta Boj, Maria Del Carmen; Jimenez Gomez, Maria Concepcion; Belmonte Martinez, Carlos; Sesto Yague, Angela; Gallar Martinez, Juana

Agent Griffith Hack

Pub. Number AU-B-2006305657

PCT Pub. Number WO2007/045930

Priority 0521351.7 20.10.05 GB

Filing date 20 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 20 October 2011

International Classifications

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/045930 Priority application(s): WO2007/045930

20 October 2011 Application Accepted

  Published as AU-B-2006305657

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006305677-A plurisubstituted hydroxyapatite and the composite thereof with a natural and/or synthetic polymer, their preparation and uses thereof

2006305654-Therapeutic agent